Evidence map›Paper›PMID 38696204›Full record

ArticleJAMA2024

Recurrent Gout and Serum Urate-Reply.

Natalie McCormick, Hyon K Choi

Abstract readLetterComment
In one paragraph

Article in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Natalie McCormickRheumatology & Allergy Clinical Epidemiology Research Center, Massachusetts General Hospital, Boston.
Hyon K ChoiRheumatology & Allergy Clinical Epidemiology Research Center, Massachusetts General Hospital, Boston.

Funding

The Effects of Urate Lowering Therapy on Inflammation, Endothelial function, andP50AR060772 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2012 to 2021
$12.8M
NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUTR01AR065944 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, HYON K · 2013 to 2025
$4.2M
Metabolic syndrome, chronic inflammation, and gout: a multi-omics approachR00AR080243 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Natalie McCormick · 2025 to 2026
$461k
Metabolic syndrome, chronic inflammation, and gout: a multi-omics approachK99AR080243 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MCCORMICK, NATALIE · 2022 to 2023
$188k
NIAMS NIH HHS K99 AR080243NIAMS NIH HHS P50 AR060772NIAMS NIH HHS R00 AR080243NIAMS NIH HHS R01 AR065944
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GoutUric AcidGout SuppressantsHumansRecurrenceGout SuppressantsUric Acid

Identifiers

PMID38696204
PMCPMC11884748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.